Basser Center for BRCA

About BRCA1 and BRCA2

Both men and women who have a BRCA1 or BRCA2 gene mutation have an increased risk for developing certain cancers, including breast, ovarian, pancreatic, and prostate cancers.

Chart showing lifetime cancer risk with BRCA mutation

About the Basser Center for BRCA

The Basser Center for BRCA at Penn Medicine’s Abramson Cancer Center, founded by Mindy and Jon Gray, is the first comprehensive center for the research, treatment, and prevention of BRCA-related cancers. The Center’s unique model provides funding for collaborative research, education, and outreach programs around the world.

The Basser Center has helped to accelerate progress for BRCA-related cancer research; including contributing to the development of FDA-approved targeted therapies for BRCA-related cancers.

Learn about our newest initiatives:

  • LATINX & BRCA: a partnership to improve awareness and provide education about BRCA-related cancers in the Latinx community.
  • Black & BRCA: a collaboration to bring tailored resources and support to the Black community, Black & BRCA seeks to empower individuals to understand their family health history and take action.